ALDOSE REDUCTASE INHIBITORS - PHARMACOLOGICAL DATA AND THERAPEUTIC PERSPECTIVES

被引:4
作者
CANAL, N [1 ]
COMI, G [1 ]
机构
[1] UNIV MILAN,SCH MED,DEPT NEUROL,I-20132 MILANO,ITALY
关键词
D O I
10.1016/0165-6147(85)90152-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:328 / 330
页数:3
相关论文
共 21 条
  • [1] DIABETIC NEUROPATHY
    BROWN, MJ
    ASBURY, AK
    [J]. ANNALS OF NEUROLOGY, 1984, 15 (01) : 2 - 12
  • [2] CANAL N, 1984, BR J CLIN PRAC S, V38, P62
  • [3] DIABETIC NEUROPATHY - NEW CONCEPTS OF ITS ETIOLOGY
    CLEMENTS, RS
    [J]. DIABETES, 1979, 28 (06) : 604 - 611
  • [4] EFFECT OF AN ALDOSE REDUCTASE INHIBITOR ON DIABETIC PERIPHERAL NEUROPATHY - PRELIMINARY-REPORT
    CULEBRAS, A
    ALIO, J
    HERRERA, JL
    LOPEZFRAILE, IP
    [J]. ARCHIVES OF NEUROLOGY, 1981, 38 (02) : 133 - 134
  • [5] POLYOL ACCUMULATION IN GALACTOSEMIC AND DIABETIC RATS - CONTROL BY AN ALDOSE REDUCTASE INHIBITOR
    DVORNIK, D
    SIMARDDU.N
    KRAMI, M
    SESTANJ, K
    GABBAY, KH
    KINOSHITA, JH
    VARMA, SD
    MEROLA, LO
    [J]. SCIENCE, 1973, 182 (4117) : 1146 - 1148
  • [6] FAGIUS J, 1981, J NEUROL NEUROSURG P, V44, P99
  • [7] KINETICS OF AN ORALLY ABSORBED ALDOSE REDUCTASE INHIBITOR, SORBINIL
    FOULDS, G
    OBRIEN, MM
    BIANCHINE, JR
    GABBAY, KH
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (05) : 693 - 700
  • [8] ALDOSE REDUCTASE INHIBITION - STUDIES WITH ALRESTATIN
    GABBAY, KH
    SPACK, N
    LOO, S
    HIRSCH, HJ
    ACKIL, AA
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1979, 28 (04): : 471 - 476
  • [9] SORBITOL PATHWAY - PRESENCE IN NERVE AND CORD WITH SUBSTRATE ACCUMULATION IN DIABETES
    GABBAY, KH
    MEROLA, LO
    FIELD, RA
    [J]. SCIENCE, 1966, 151 (3707) : 209 - &
  • [10] SORBITOL PATHWAY - ENZYME LOCALIZATION AND CONTENT IN NORMAL AND DIABETIC NERVE AND CORD
    GABBAY, KH
    OSULLIVA.JB
    [J]. DIABETES, 1968, 17 (05) : 239 - &